共 151 条
[1]
Siegel RL(2017)Cancer statistics, 2017 CA Cancer J Clin 67 7-30
[2]
Miller KD(2013)Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry Gastric Cancer 16 1-27
[3]
Jemal A(2007)Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810-1820
[4]
Nashimoto A(2012)Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Lancet 379 315-321
[5]
Akazawa K(2011)Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer J Clin Oncol 29 4387-4393
[6]
Isobe Y(2017)Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy Gastric Cancer 20 175-181
[7]
Miyashiro I(2011)Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer Cancer Chemother Pharmacol 67 1423-1428
[8]
Katai H(2014)Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer Gastric Cancer 17 383-386
[9]
Kodera Y(2011)Japanese classification of gastric carcinoma: 3rd English edition Gastric Cancer 14 101-112
[10]
Tsujitani S(2016)The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis Gastric Cancer 19 696-712